Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hematopoietic defects and iPSC disease modeling: lessons learned.

Immunology letters - 1 Jan 2000

Kelley James M, Daley George Q

Abstract excerpt

Hematopoiesis is a paradigm for stem cell biology in that it centers on differentiation of a self-renewing pluripotent precursor into multiple committed cell types with specific functions. The use of induced pluripotent stem cells (iPSCs) as a disease modeling tool has revealed numerous insights into the underlying pathophysiology of hematological diseases - those disorders arising from defective hematopoiesis....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Differentiation
Share to Cellular Reprogramming
Share to Hematologic Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoiesis

Share to Hematopoietic Stem Cell Transplantation

Share to Hematopoietic Stem Cells

Share to Hemoglobins

Share to Induced Pluripotent Stem Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 24076116
DOI: 10.1016/j.imlet.2013.09.018
PMCID: PMC3888024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hematopoietic defects and iPSC disease modeling: lessons learned.PMID 24076116Read ↗

Modeling blood diseases with human induced pluripotent stem cellsSemantic proximity Read ↗

Recent Updates on Induced Pluripotent Stem Cells in Hematological DisordersSemantic proximity Read ↗

Application of iPS cells derived from congenital myelodysplastic syndrome for research of nomal hematopoesis and hematological malignancies.Semantic proximity Read ↗

Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based TherapiesSemantic proximity Read ↗

Induced pluripotent stem cells as a tool for gaining new insights into Fanconi anemia.Semantic proximity Read ↗

Hematopoietic stem cells.Semantic proximity Read ↗

GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.Semantic proximity Read ↗

Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell linesSemantic proximity Read ↗

Modeling primitive and definitive erythropoiesis with induced pluripotent stem cellsSemantic proximity Read ↗

Hematopoietic stem cell engineering at a crossroadsSemantic proximity Read ↗

Generation of complex bone marrow organoids from human induced pluripotent stem cellsSemantic proximity Read ↗

Hematopoietic stem cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.